For the Quarter Ending September 2025
North America
• In United States, the Salbutamol Sulphate Price Index remained stable in Q3 2025, influenced by mixed macroeconomic signals.
• Production costs rose due to a 2.6% year-over-year PPI increase in August 2025, reflecting higher input expenses.
• Demand outlook supported by 5.42% retail sales rise and 4.3% unemployment rate in September 2025.
• Declining consumer confidence to 94.2 in September 2025 suggested potential future constraints on healthcare spending.
• Chemical manufacturing activity contracted in Q3 2025, despite a marginal 0.1% industrial production increase in September 2025.
• Feedstock benzene costs strengthened in July and August 2025, elevating phenol production expenses for Salbutamol Sulphate.
• US pharmaceutical exports decreased year-on-year in July 2025, while imports increased, expanding the sector's trade deficit.
• Salbutamol Sulphate price forecast stable, with 3.0% CPI in September 2025 balanced by easing phenol prices.
Why did the price of Salbutamol Sulphate change in September 2025 in North America?
• Phenol prices eased in September 2025 due to elevated inventories, moderating Salbutamol Sulphate production costs.
• A 3.0% year-over-year CPI increase in September 2025 indicated general inflationary pressure on operational expenses.
• Robust retail sales, up 5.42% year-over-year in September 2025, supported consumer affordability.
APAC
• In China, the Salbutamol Sulphate Price Index fell quarter-over-quarter in Q3 2025, due to deflationary pressures and persistent oversupply.
• Salbutamol Sulphate production costs faced downward pressure in September 2025, as producer prices declined 2.3% year-over-year.
• Demand for Salbutamol Sulphate is supported by 3.0% retail sales growth in September 2025 and expanding healthcare.
• China's pharmaceutical market saw robust growth in 2025, driven by an aging population and rising chronic diseases.
• Petrochemical feedstock prices for Salbutamol Sulphate held steady throughout Q3 2025 amid global overcapacity.
• The Manufacturing Index contracted in September 2025, reflecting reduced industrial activity affecting supply chains.
• Industrial production, however, expanded 6.5% year-over-year in September 2025, indicating growth in manufacturing.
• New export orders for China's manufacturing sector strengthened in September 2025, increasing after several months.
• Consumer confidence remained low at 89.6 in September 2025, with 5.2% unemployment, dampening spending.
• Government policy in September 2025 aims to optimize capacity and foster high-value specialty chemicals.
Why did the price of Salbutamol Sulphate change in September 2025 in APAC?
• Consumer Price Index declined 0.3% in September 2025, indicating deflationary pressures and price erosion.
• Producer Price Index fell 2.3% in September 2025, suggesting lower input costs for production.
• Low consumer confidence at 89.6 and 5.2% unemployment dampened pharmaceutical demand.
Europe
• In Germany, the Salbutamol Sulphate Price Index rose quarter-over-quarter in Q3 2025, driven by elevated raw material and operational costs.
• Salbutamol Sulphate production costs faced upward pressure from a 2.4% CPI increase in September 2025, impacting operations.
• Producer prices fell 1.7% in September 2025 due to lower energy costs, partially offsetting production burdens.
• Demand for pharmaceutical products, including Salbutamol Sulphate, strengthened in Germany during Q3 2025.
• The Manufacturing Index contracted in Q3 2025, indicating a broader slowdown affecting Salbutamol Sulphate supply chains.
• German industrial production declined 1.0% in September 2025, indirectly impacting non-API components and logistics.
• Retail sales increased 0.2% in September 2025, suggesting a stable consumer economy supporting healthcare spending.
• The unemployment rate remained stable at 6.3% in September 2025, potentially straining healthcare access and funding.
• European natural gas spot prices eased in Q3 2025, reducing energy feedstock costs for Salbutamol Sulphate manufacturing.
Why did the price of Salbutamol Sulphate change in September 2025 in Europe?
• Elevated raw material costs and 2.4% CPI increase in September 2025 pressured Salbutamol Sulphate prices.
• Easing natural gas prices and 1.7% PPI decrease in September 2025 partially offset production costs.
• Strengthening pharmaceutical demand in Q3 2025 supported Salbutamol Sulphate prices despite industrial weakness.
